ArticleBiomedical optics express2025
Quantification of oxidized and reduced cytochrome-c-oxidase by combining discrete-wavelength time-resolved and broadband continuous-wave near-infrared spectroscopy.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Advancements in broadband near-infrared spectroscopy instrumentation for the assessment ofJournal of biomedical optics · 2025Pooled it
- Neonatal cerebral hemodynamics under elevated intracranial pressure: a near-infrared spectroscopy study in piglets.Pediatric research · 2026Article
- MW-FlexNIRS: wearable, low-cost, LED-based, multi-wavelength NIRS oximeter for cytochrome c oxidase recovery in neonates.Biomedical optics express · 2026Article
- Optical and Microdialysis Monitoring of Succinate Prodrug Treatment in a Rotenone-Induced Model of Mitochondrial Dysfunction in Swine.Metabolites · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quantification of cytochrome-c-oxidase (CCO) can directly inform about cerebral metabolic capacity and function, but limited options currently exist for its in vivo assessment. Near-infrared spectroscopy (NIRS) has the potential to quantify CCO and its redox states, but hyperspectral absorption measurements are required due to their broad absorption profiles and low concentrations relative to hemoglobin. While this may be achieved with continuous-wave broadband NIRS (bNIRS), separating the signal contributions of absorption and scattering remains a challenge. Alternatively, time-resolved NIRS (trNIRS) can directly disentangle absorption and scattering but is typically constrained to a few wavelengths. This work aimed to develop an approach for quantifying absolute CCO concentration using discrete-wavelength trNIRS to calibrate bNIRS, yielding calibrated bNIRS (cbNIRS). Monte-Carlo simulations were conducted to validate the algorithm. Subsequently, a hybrid cbNIRS system was assembled, and tissue-mimicking phantoms were prepared with blood, Intralipid, and either yeast or sodium dithionite for validation. The simulations demonstrated that the algorithm can accurately measure absorption across the spectral range (error = 0.8 ± 0.4%). Further, the concentrations of CCO and its different redox states were estimated with an error of 7.9% or less. In the phantom experiments, the measured HbT concentration increased with the addition of blood, but not yeast nor sodium dithionite, and the value agreed with the expected concentration estimated from the packed cell volume of blood. A large increase in total CCO was measured only after the addition of yeast (1.8 ± 0.4
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.